LCM
CERE

Laurion Capital Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Laurion Capital Management’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-7,361
Closed -$301K – 637
2024
Q2 		$301K Buy
+7,361
New +$307K ﹤0.01% 426

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Laurion Capital Management's CERE Position: Q3 2024 in Review

Laurion Capital Management sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 7,361 shares — an estimated $301K sold.

Laurion Capital Management first reported a position in CERE in Q2 2024 and held it in 1 quarter. The position peaked at $301K in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Laurion Capital Management reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Laurion Capital Management sold 7,361 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $301K.
  • Laurion Capital Management first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2024 and held it in 1 quarter.
  • Laurion Capital Management's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $301K in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Laurion Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.